Panorama™ is a blood-based genetic, prenatal screening test of the pregnant person that screens for common chromosomal conditions that affect a baby’s health. In addition to the most common syndromes, this test also screens for 22q11.2 deletion, the second most common condition after Down Syndrome.
Panorama™ can be performed as early as nine weeks gestation. Most results will be returned within 7 business days from the date that samples are taken.
Panorama™ is a screening test, which means that this test does not make a final diagnosis. A high risk result means that your pregnancy has a higher chance of having a specific genetic condition. However, you cannot know for sure if your baby has that condition based upon the screening result alone. All medical decisions should be made after discussion with your healthcare provider regarding diagnostic testing during the pregnancy, like chorionic villus sampling (CVS) or amniocentesis, or testing the baby after birth.
This package includes an early pregnancy scan.
Conditions Screened For
- Trisomy 21 (Down Syndrome)
- Trisomy 18 (Edwards Syndrome)
- Trisomy 13 (Patau Syndrome)
- Sex chromosome aneuploides: A sex chromosome aneuploidy results from an additional or missing sex chromosome. Approximately 1 in 400 babies born are born with a sex chromosome aneuploidy
- 22q11.2 Deletion Syndrome
- Triploidy: Babies with triploidy have a complete extra set of chromosomes for a total of 69 chromosomes instead of the usual 46.
- Optional foetal sex chromosome screening*
The Technology
Panorama™ uses SNP*-based technology to deliver highly accurate results and unique insights for both singleton and twin pregnancies.
- The only SNP-based NIPT, designed to inform decisions during pivotal moments of pregnancy care.
- A differentiated, highly-accurate screening approach evaluates SNPs – the 1% of our DNA that makes us different from one another – to screen for common trisomies, aneuploidies and microdeletions.
- A sequencing platform of >13K SNPs enables Panorama to deliver a curated prenatal cfDNA screening test that accounts for all ethnicities and population variability.
*SNP, single nucleotide polymorphism
The Procedure
- Please arrive 10 minutes before your appointment time. You will be welcomed at our clinic and asked to complete consent forms for the scan and for the genetic screening.
- When ready, the sonographer will welcome you in the consultation room, confirm your details, the reason for your scan and discuss any particular concerns you may have.
- The sonographer will perform a scan and will discuss with you what she / he are seeing.
- When ready, the sonographer will then proceed, with your consent, to take a sample of your blood from your arm.
- At the end of the appointment, you will be invited back to the reception room where you can collect your scan report.
- The results of your genetic screening should be expected indicatively within 10 days via an email from our clinic.
Results
- Panorama™ offers a personalized report, which indicates whether your baby has a high or low chance for developing certain genetic conditions. Panorama™ NIPT results are available within 1 week from the time your sample is received at Natera.Your report could state the following:
- Low Risk: A low risk result means that the chance that your baby has one of the conditions tested by Panorama is very unlikely but not zero — less than 1 in 10,000 for most conditions
- High Risk: Panorama is a screening test, which means that this test does not make a final diagnosis. A high risk result means that your pregnancy has a higher chance of having a specific genetic condition. However, you cannot know for sure if your baby has that condition based on screening results alone. If you receive a high risk Panorama result, speak with your healthcare provider (HCP) to discuss which next steps you could decide to pursue, such as genetic counseling, detailed ultrasound, and the option of diagnostic testing. All medical decisions should be made after discussion with your HCP regarding diagnostic testing during the pregnancy, like chorionic villus sampling (CVS) or amniocentesis, or testing the baby after birth.
- No results: About 1 in 65 tests could receive a nonreportable result.3 You should speak with your HCP about these result types and whether you should consider having a second blood draw to do the test again. There is also a small chance that Panorama will have a result relating to your genetics or your physical health
- >99% combined sensitivity for trisomies (T21, T18, T13)
- 83% clinical sensitivity for 22q11.2 deletions (0.5 Mb+ deletions)
- >95% positive predictive value (PPV) for trisomy 21
- Zero fetal sex errors in validation studies
Suitability
This test cannot currently be used by women carrying three or more babies (triplets and above), women who have used an egg donor or surrogate carrying more than one baby (twins or triplets), or those who have received a bone marrow transplant.